United States · 
Who invested in Blue Note Therapeutics?
Blue Note Therapeutics's investors include Alumni Ventures.
United States · Series A startup
Who invested in Blue Note Therapeutics
Funding summaryUpdated 26 Oct 2026
$5.2Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $5.2MSept 2021
- Investors
- 1
The rounds
- Sept 2021
Founders and team
From the SEC filings it signed: 1 on the team.
- Geoffrey EichExecutive Officer, Directori
On the board, as filediAndrew FirlikJohn Harris
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Blue Note Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Blue Note Therapeutics
How much has Blue Note Therapeutics raised?
Blue Note Therapeutics has raised $5.2M across 1 round since 2021.
When did Blue Note Therapeutics last raise?
Blue Note Therapeutics's most recent round was a Series A of $5.2M in Sept 2021.
What was Blue Note Therapeutics's biggest round?
Its most recent round, $5.2M in Sept 2021, is also its largest on record.
Who backed Blue Note Therapeutics first?
Blue Note Therapeutics's first round on record, in Sept 2021, was backed by Alumni Ventures.
What stage is Blue Note Therapeutics at?
Blue Note Therapeutics's latest named round is a Series A, in Sept 2021.
Where is Blue Note Therapeutics based?
Blue Note Therapeutics is based in the United States.
Companies like Blue Note Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.